Identification of Biomarkers for Investigating Osteopathic Manipulative Treatment

West Virginia School of Osteopathic Medicine2 个研究点分布在 1 个国家目标入组 40 人开始时间: 2009年8月最近更新: 2011年7月13日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: West Virginia School of Osteopathic Medicine
入组人数: 40
试验地点: 2
主要终点: Salivary amylase levels

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study is to identify non-invasive biomarkers of the physiologic response to Osteopathic Manipulative Treatment (OMT).

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Crossover
主要目的: Basic Science
盲法: Single (Participant)

入排标准

年龄范围: 21 Years 至 60 Years（Adult）
性别: All
接受健康志愿者: 是

入选标准

•Healthy adults between the ages of 21 and 60

排除标准

•Eating or drinking anything but water or chewing gum within an hour of the appointment
•Rib fracture
•History of unstable cardiac arrhythmia or symptoms related to the chest cavity (difficulty breathing, chest pain)
•Symptoms suggestive of bowel obstruction (abdominal bloating with pain, nausea and vomiting, diarrhea)
•Pregnancy
•History of Sjogren's Syndrome

结局指标

主要结局

Salivary amylase levels

时间窗: baseline, 10 minutes post procedure

次要结局

未报告次要终点

研究者

发起方

West Virginia School of Osteopathic Medicine

申办方类型

Other

研究点 (2)

Loading locations...

相似试验

招募中

2 期

Biomarkers to Detect Endocrine Therapy ResistanceMetastatic CancerLobular Breast CarcinomaBreast Cancer

NCT06067503University of Wisconsin, Madison8

已完成

不适用

A Study to Assess Selected Biomarkers in Subjects Requiring Daily Inhaled Corticosteroids for Persistent AsthmaAsthma

NCT01334853MedImmune LLC97

招募中

不适用

Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction CancerEsophageal Cancer (EsC)

NCT06713993Semmelweis University100

已完成

不适用

Epidural Lavage Study for Lumbar StenosisLumbar Spinal Stenosis

NCT03511053Dallas VA Medical Center11

进行中（未招募）

1 期

Clinical trial for the identification of biomarkers based on omic techniques (study of large amounts of data), and their inter and intra-individual variability that allow the improvement in the individualization of tacrolimus treatment in pediatric patients with renal transplantation.Pediatric patients with renal transplantation (under stable treatment with tacrolimus as immunosuppressant)

EUCTR2019-002795-13-ESFundación de Investigación Hospital Universitario La Paz180